PRTODAY / NewswireToday Free press release distribution service network

More news: Software
Written by / Agency / Source: Oracle Corporation

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Oracle Health Sciences Adds 93 Emerging Biopharmaceutical Customers - Oracle’s industry-leading clinical R&D cloud solutions help emerging biopharmaceutical firms optimize clinical development productivity and facilitate compliance, while delivering an affordable pricing model and rapid deployment - Oracle.com
Oracle Health Sciences Adds 93 Emerging Biopharmaceutical Customers

 

NewswireToday - /newswire/ - Redwood Shores, CA, United States, 2015/09/29 - Oracle’s industry-leading clinical R&D cloud solutions help emerging biopharmaceutical firms optimize clinical development productivity and facilitate compliance, while delivering an affordable pricing model and rapid deployment - Oracle.com. NYSE, NASDAQ: ORCL

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Software Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Emerging biopharmaceutical organizations face a growing number of regulatory requirements and, due to increased competition1, acute pressure to speed time to market. Today, Oracle Health Sciences announced that 93 of these emerging biopharma organizations worldwide have become new customers in the past year, adopting Oracle Health Sciences solutions to succeed in this rapidly evolving market and deliver drugs to patients faster.

Biopharmaceutical organizations, including sponsors such as Accera and NewLink Genetics and contract research organizations (CROs) FMD K&L and 4C Pharma Solutions, selected Oracle Health Sciences solutions to manage their end-to-end clinical trial processes, boost clinical development productivity, facilitate compliance, and build scalable, affordable platforms for growth.

“Oracle has long been a trusted partner working alongside smaller, emerging firms by developing innovative solutions to help them grow,” said Steve Rosenberg, senior vice president and general manager, Oracle Health Sciences. “Our industry-leading clinical development, management, and safety solutions deploy rapidly and scale on demand, empowering emerging biopharmas to optimize clinical productivity, focus resources on innovation, and manage critical regulatory requirements with confidence.”

With the robust functionality of the Oracle Health Sciences suite of industry-leading cloud solutions2 such as Oracle Health Sciences InForm, Oracle Health Sciences IRT, Oracle Argus, Oracle’s Siebel Clinical Trial Management System, and Oracle Health Sciences ClearTrial Plan and Source Enterprise Edition Cloud Service, these emerging organizations can now optimize productivity and navigate complex regulatory compliance requirements with ease.

FMD K&L adopted Oracle Health Sciences InForm to help ensure data accuracy and efficiencies.

“We are dedicated to providing high-quality results to get our clients’ drug or medical products approved quickly,” said Dr. Xin Ke, president, FMD K&L. “Oracle Health Sciences InForm is a proven, industry-leading clinical data management system that enables us to raise the standard of excellence through accuracy and consistency on a continuous basis. Additionally, the ability to collaborate with Oracle on developing industry standards and implementation best practices has been invaluable in improving the quality and efficiency of our services.”

The Oracle Health Sciences cloud platform also provides an efficient model for predictable costs. Accera, a biotechnology company focused on conditions affecting the central nervous system, uses cloud-based Oracle Health Sciences ClearTrial Plan and Source Enterprise Edition Cloud Service to model scenarios for future trials.

The solution helps Accera to communicate the implications of different scenarios to investors and other stakeholders. It also gives Accera a benchmark for cost comparisons, and helps with financial projections and forecasting for each scenario. This allows Accera personnel to use time and resources more efficiently in the critical planning stages of their clinical development programs.

4C Pharma Solutions and NewLink Genetics use Oracle Argus Safety to gain greater insight into product-safety issues, improve productivity, and streamline safety reporting.

“As the life sciences industry becomes more regulated in reference to drug safety, we believe in providing customized, reliable, cost-effective, and global solutions while building long-lasting relationships to provide a great experience,” said Yathendra Madineni, M.D., CEO, 4C Pharma Solutions. “We build with trust, prove with quality, and truly make our partners’ requirements our passion. With Oracle Argus Safety solutions, our team can help our partners focus on research and innovation while we take care of the rest.”

NewLink Genetics is a biopharmaceutical company focused on discovering, developing, and commercializing immuno-oncology products that activate the body’s immune system to identify and attack cancer cells. By implementing the centralized database within Siebel Clinical Trial Management System, NewLink Genetics can manage its clinical trial activities and improve relationships with investigators, from early to late-stage studies.

“We develop multifaceted treatment strategies and several immuno-oncology agents through clinical trials enrolling patients at sites worldwide,” said Eugene P. Kennedy, M.D., vice president of Clinical and Medical Affairs, NewLink Genetics. “As we push forward to bring much needed treatment options that will revolutionize the way we treat patients with cancer, our team utilizes Oracle Health Sciences solutions for real-time visibility into our operational performance and regulatory compliance requirements.”

By offering a tailored business model to address the unique needs of the emerging biopharmaceutical market, Oracle Health Sciences provides these emerging firms with access to an innovative, affordable, and best-of-breed suite of e-clinical solutions. Further, the Oracle CRO Advantage program provides CROs serving the biopharmaceutical sector with a portfolio of integrated technologies; business development, sales enablement, and training solutions; and joint marketing opportunities that can enhance market success.

Contact: Mary Tobin - O’Keeffe & Company
P: +1 503-658-7396 - E: mtobin[.]okco.com.

About Oracle
Oracle (oracle.com) offers a comprehensive and fully integrated stack of cloud applications and platform services.

Trademarks
Oracle and Java are registered trademarks of Oracle and/or its affiliates. Other names may be trademarks of their respective owners.

1. DiMasi JA, Faden LB. “Follow‐on Drug R&D: New Data on Trends in Entry Rates and the Timing of Development,” Tufts Center for the Study of Drug Development Working Paper, Boston, Mass.: CSDD. September 2009. Accessed March 2015.

2. IDC Health Insights,“Vendor Assessment: 2014 Top 10 Life Science Software Vendors,” Eric Newmark and Alan S. Louie, March 2015.
Safe Harbor

The following is intended to outline our general product direction. It is intended for information purposes only, and may not be incorporated into any contract. It is not a commitment to deliver any material, code, or functionality, and should not be relied upon in making purchasing decisions. The development, release, and timing of any features or functionality described for Oracle's products remains at the sole discretion of Oracle Corporation.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Software Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Oracle Corporation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
Software Warnings - IMPORTANT:
Always be aware/cautious about what you download on your computer/mobile! PURCHASE SOFTWARE related keywords / Banner Ads. Click HERE for details!
.

 
  Your Banner Ad showing on ALL
Software articles,
CATCH Visitors via Your Competitors Announcements!


Oracle Health Sciences Adds 93 Emerging Biopharmaceutical Customers

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Oracle Health Sciences |
Publisher Contact: Samantha Thai - Oracle.com 
510-917-5564 samantha.thai[.]oracle.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Oracle Corporation securities in any jurisdiction including any other companies listed or named in this release.

Software via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Oracle Corporation / Company Profile


Read Software Most Recent Related Newswires:

Yellowfin Launches Analytics Industry’s First Virtualized Integrated Data Preparation Module
Comways and Altitude Highlight Flexible Solutions at Belgium Contact Center Congress
IBM Launches New Bluemix Services with GitHub and Slack Integration to Speed App Development in the Cloud
TIBCO Releases TIBCO Mashery Local API Management Solution for Hybrid Gateway Deployments
Gruppo Campari Chooses OpenText Business Network for B2B Growth
Infor Delivers Enhanced Mobile Equipment Solution
Mentor Graphics and SiliconIndia Announce 2016 Leadership Awards for the Embedded/VLSI Industry
Korean Retailer Homeplus Optimizes Store Planning with JDA Category Management
IBM and Pfizer to Accelerate Immuno-oncology Research with Watson for Drug Discovery
The VELUX Group to Drive Smart Product Innovation with Implementation of PTC Windchill Across the Enterprise
KPIT Takes A Strategic Stake in A Germany Headquartered Automotive Engineering Services Company
Pegasystems Named Silver Winner for Best New Product of the Year in Best in Biz Awards 2016
Kentico Releases its Most Enterprise-Ready Solution Yet
OneLogin Delivers First-Ever Multi-Environment AWS User Resource Provisioning
Mahindra and IBM to Develop Blockchain Solution for Supply Chain Finance

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Triggr & Bloom

Visit  BizJobs.com





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)